|
⚲
|
| Keyboard |
| Biocancell Therapeutics Inc
✚
|
|
|---|---|
| CIK # | 0001451980 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 10-K | [0001451980] | |
| 10-Q | [0001451980] | |
| 4 | [0001451980] | |
| 8-K | [0001451980] | |
| SC 13D | [0001451980] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| CLAL Biotechnology Industries Ltd | Biocancell Therapeutics Inc | [2012-03-07] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Biocancell Therapeutics Inc BICL
Common stock
|
2012-07-31 | Conversion | 4,147,171 | $0.22 | 912,378 |
|
Biocancell Therapeutics Inc BICL
Debenture · derivative
|
2012-07-31 | Conversion | |||
|
Biocancell Therapeutics Inc BICL
Common stock
|
2012-07-31 | Buy | 10,731,726 | $0.22 | 2,360,980 |
|
Biocancell Therapeutics Inc BICL.TA
Employee Options · derivative
|
2012-02-12 | Grant | 300,000 | $0.00 | |
|
Biocancell Therapeutics Inc BICL
Common stock
|
2012-01-24 | Other | 410,392 | $0.00 | |
|
Biocancell Therapeutics Inc BICL
Common stock
|
2012-01-24 | Buy | 8,199,400 | $0.26 | 2,131,844 |
|
Biocancell Therapeutics Inc BICL.TA
Employee Options · derivative
|
2011-09-27 | Grant | 200,000 | $0.00 | |
|
Biocancell Therapeutics Inc BICL.TA
Employee Options · derivative
|
2011-09-27 | Grant | 60,000 | $0.00 | |
|
Biocancell Therapeutics Inc BICL.TA
Employee Options · derivative
|
2011-09-27 | Grant | 300,000 | $0.00 |